These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 32890133
1. Inhibition of Glycogen Synthase Kinase 3β Alleviates Chronic Renal Allograft Dysfunction in Rats. Deng J, Wang X, Zhou Q, Xia Y, Xiong C, Shao X, Zou H. Transplantation; 2021 Apr 01; 105(4):757-767. PubMed ID: 32890133 [Abstract] [Full Text] [Related]
2. GSK-3β Inhibitor Induces Expression of the TLR4/MyD88/NF-κB Signaling Pathway to Protect Against Renal Ischemia-Reperfusion Injury During Rat Kidney Transplantation. Su S, Zhang P, Zhang Q, Yin Z. Inflammation; 2019 Dec 01; 42(6):2105-2118. PubMed ID: 31440938 [Abstract] [Full Text] [Related]
3. Protective effect of rosiglitazone on chronic renal allograft dysfunction in rats. Deng J, Xia Y, Zhou Q, Wang X, Xiong C, Shao X, Shao M, Zou H. Transpl Immunol; 2019 Jun 01; 54():20-28. PubMed ID: 30682409 [Abstract] [Full Text] [Related]
4. The association between activation of the ERK1/2-NF-κB signaling pathway by TIMP2 expression and chronic renal allograft dysfunction in the CRAD rat model. Chen T, Wu S, Feng L, Long S, Liu Y, Zhang C, Lu W, Shen Y, Jiang S, Chen W, Hong G, Zhou L, Wang F, Luo Y, Zou H. Transpl Immunol; 2024 Feb 01; 82():101984. PubMed ID: 38184210 [Abstract] [Full Text] [Related]
5. Expression and significance of Sirt1 in renal allografts at the early stage of chronic renal allograft dysfunction. Xia Y, Deng J, Zhou Q, Shao X, Yang X, Sha M, Zou H. Transpl Immunol; 2018 Jun 01; 48():18-25. PubMed ID: 29452170 [Abstract] [Full Text] [Related]
6. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway. Feng X, Guan W, Zhao Y, Wang C, Song M, Yao Y, Yang T, Fan H. J Cell Physiol; 2019 Aug 01; 234(10):18994-19009. PubMed ID: 30919976 [Abstract] [Full Text] [Related]
7. The Association Between Oxidative Stress Alleviation via Sulforaphane-Induced Nrf2-HO-1/NQO-1 Signaling Pathway Activation and Chronic Renal Allograft Dysfunction Improvement. Lv D, Zhou Q, Xia Y, You X, Zhao Z, Li Y, Zou H. Kidney Blood Press Res; 2018 Aug 01; 43(1):191-205. PubMed ID: 29466800 [Abstract] [Full Text] [Related]
8. Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus. Collino M, Thiemermann C, Mastrocola R, Gallicchio M, Benetti E, Miglio G, Castiglia S, Danni O, Murch O, Dianzani C, Aragno M, Fantozzi R. Shock; 2008 Sep 01; 30(3):299-307. PubMed ID: 18323734 [Abstract] [Full Text] [Related]
9. Inhibition of GSK-3β Alleviates Collagen II-Induced Rheumatoid Arthritis in Rats. Zhou H, Liu J, Zeng J, Hu B, Fang X, Li L. Med Sci Monit; 2016 Mar 31; 22():1047-52. PubMed ID: 27029564 [Abstract] [Full Text] [Related]
10. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β). Lohning A, Kidachi Y, Kamiie K, Sasaki K, Ryoyama K, Yamaguchi H. Eur J Med Chem; 2021 Apr 15; 216():113250. PubMed ID: 33691258 [Abstract] [Full Text] [Related]
11. Lupus nephritis: glycogen synthase kinase 3β promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice. Zhao J, Wang H, Huang Y, Zhang H, Wang S, Gaskin F, Yang N, Fu SM. Arthritis Rheumatol; 2015 Apr 15; 67(4):1036-44. PubMed ID: 25512114 [Abstract] [Full Text] [Related]
12. Inhibition of glycogen synthase kinase 3β improves cognitive function in aged mice by upregulating claudin presences in cerebral endothelial cells. Liang T, Ju H, Zhou Y, Yang Y, Shi Y, Fang H. Acta Biochim Biophys Sin (Shanghai); 2020 Apr 20; 52(4):363-370. PubMed ID: 32141492 [Abstract] [Full Text] [Related]
13. Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway. Wen Y, Liu Y, Huang Q, Liu R, Liu J, Zhang F, Liu S, Jiang Y. Phytomedicine; 2022 Jan 20; 95():153856. PubMed ID: 34856477 [Abstract] [Full Text] [Related]
14. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Dugo L, Collin M, Allen DA, Patel NS, Bauer I, Mervaala EM, Louhelainen M, Foster SJ, Yaqoob MM, Thiemermann C. Crit Care Med; 2005 Sep 20; 33(9):1903-12. PubMed ID: 16148458 [Abstract] [Full Text] [Related]
17. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor. Capurro V, Lanfranco M, Summa M, Porceddu PF, Ciampoli M, Margaroli N, Durando L, Garrone B, Ombrato R, Tongiani S, Reggiani A. Biomed Pharmacother; 2020 Aug 20; 128():110249. PubMed ID: 32470749 [Abstract] [Full Text] [Related]
19. Glycogen Synthase Kinase-3β Inhibitor Attenuates Renal Damage Through Regulating Antioxidant and Anti-inflammation in Rat Kidney Transplant With Cold Ischemia Reperfusion. Hu B, Tang J, Zhang Y, Ma Z, Shan Y, Liu J, Shen X, Qian P. Transplant Proc; 2019 Aug 20; 51(6):2066-2070. PubMed ID: 31399185 [Abstract] [Full Text] [Related]
20. Establishment of Rat Model of Insulin Resistance Exposed to Chronic Renal Allograft Dysfunction. Tang J, Cai D, Jin X, Zhang Y, Qian X, Shen R, Hu B, Jin L, Chen D. Transplant Proc; 2021 Aug 20; 53(1):486-490. PubMed ID: 32768286 [Abstract] [Full Text] [Related] Page: [Next] [New Search]